Industry News
PEG Derivatives for Long Acting rhG-CSF
G-CSFs have become the major therapeutic option for the treatment of patients with neutropenia.
Peptide-Drug Conjugates Approvals and In …
Currently, there are only two PDCs approved for therapeutic use globally and 40+ PDCs in clinical trails.
What Is Piroctone Olamine, Can It Get Rid…
Piroctone Olamine is an effective ingredient for controlling dandruff and promoting a healthy scalp.
TROP-2 directed antibody-drug conjugates …
Trop2 has gained significant attention in antibody-drug conjugate (ADC) research as a potential therapeutic target due to its widespread expression in tumor tissues and limited expression in …
Pro-xylane – Powerful Cosmetic Ingredien…
Pro-xylane, also known as hydroxyethyl tetrahydropyrantriol, is an anti-aging active substance that promotes the synthesis of collagen.
Advances in Nonalcoholic Fatty Liver Dise…
The U.S. FDA has not yet approved any drugs for NASH treatment. The search for an effective and safe treatment for NASH is urgent.
Classification of Anticoagulant Drugs
4 types of anticoagulants: Vitamin K antagonists (VKA), indirect thrombin inhibitors, direct thrombin inhibitors and factor Xa inhibitors. and Representative Drugs
Semaglutide Indication Opportunity: From …
On October 10, 2023, Novo Nordisk announced the early termination of a Phase 3 clinical trial of semaglutide for the treatment of patients with kidney injury and chronic kidney disease who ha…
Nectin-4 ADCs for Cancer Treatment
At present, only one Nectin-4 ADC drug, Padcev (enfortumab vedotin), has been approved for marketing for the second-line treatment of patients with uroepithelial cancer.
ADCs for HER2-Positive, HER2-Negative &am…
Here, we will analyze the three FDA approved ADCs for the HER2-positive, HER2-low, and HER2-negative breast cancers.
sales@huatengusa.com
+86 0731 89916275